A detailed history of Revolve Wealth Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Revolve Wealth Partners, LLC holds 16,679 shares of PFE stock, worth $439,658. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,679
Previous 15,218 9.6%
Holding current value
$439,658
Previous $425,000 13.41%
% of portfolio
0.08%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $40,469 - $45,860
1,461 Added 9.6%
16,679 $482,000
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $68,884 - $80,719
-2,727 Reduced 15.2%
15,218 $425,000
Q1 2024

Apr 15, 2024

SELL
$25.89 - $29.73 $30,343 - $34,843
-1,172 Reduced 6.13%
17,945 $497,000
Q4 2023

Jan 12, 2024

SELL
$26.13 - $33.94 $7,133 - $9,265
-273 Reduced 1.41%
19,117 $550,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $32,122 - $37,547
-1,001 Reduced 4.91%
19,390 $643,000
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $41,610 - $48,142
1,152 Added 5.99%
20,391 $747,000
Q1 2023

Apr 06, 2023

SELL
$39.39 - $51.28 $123,251 - $160,455
-3,129 Reduced 13.99%
19,239 $784,000
Q4 2022

Jan 17, 2023

BUY
$41.75 - $54.5 $102,746 - $134,124
2,461 Added 12.36%
22,368 $0
Q3 2022

Oct 12, 2022

SELL
$43.76 - $53.42 $31,726 - $38,729
-725 Reduced 3.51%
19,907 $871,000
Q2 2022

Jul 11, 2022

SELL
$46.53 - $55.17 $53,230 - $63,114
-1,144 Reduced 5.25%
20,632 $1.08 Million
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $7,045 - $8,730
154 Added 0.71%
21,776 $1.13 Million
Q4 2021

Feb 04, 2022

BUY
$41.32 - $61.25 $893,421 - $1.32 Million
21,622 New
21,622 $1.28 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Revolve Wealth Partners, LLC Portfolio

Follow Revolve Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Revolve Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Revolve Wealth Partners, LLC with notifications on news.